Mayo Clinic College of Medicine and Science

He provides medical leadership for the company's colorectal cancer screening portfolio, including the well-known Cologuard multi-target stool DNA test and ongoing innovations in non-invasive early detection.

He's a professor emeritus of medicine at the Mayo Clinic College of Medicine and was co-leader of the Cancer Prevention and Control Program in the Mayo Clinic Cancer Center.

He's a longtime gastroenterologist and cancer prevention researcher focused on colorectal cancer screening, chemo prevention, molecular epidemiology, and improving adherence to evidence-based drugs.

He's a principal investigator for the National Cancer Institute-funded Cancer Prevention Network.

More than 90% of patients diagnosed with PTSD have sleep disturbances.

To discuss these symptoms and the role of the sleep specialist in their management, My guest today is Dr. Bhanu Kohler, professor of psychiatry at the Mayo Clinic College of Medicine and Science and a board-certified specialist in both sleep medicine and addiction medicine.

Bhanu, let's start with the highly distressing trauma-related nightmares characteristic of PTSD.

So many of us have occasional nightmares.

Many of our patients have tried cannabinoids to help with various sleep disorders.

To discuss cannabinoids and sleep My guest today is Dr. Banu Kola, professor of psychiatry at the Mayo Clinic College of Medicine and Science and a board-certified specialist in both areas, sleep medicine and addiction medicine, so an ideal person to discuss this area.

So, Banu, the brain and the body are primed to respond to exogenous cannabinoid compounds and because there is a little-known physiologic endocannabinoid system with receptors in both the nervous system and other organs.

Tell us briefly about this system.

Matthew Kohlstrom.

Dr. Kohlstrom is a professor of radiology at Mayo Clinic College of Medicine and Science in Rochester, Minnesota.

He's here to tell us all about AI's capabilities in medicine, which parts of healthcare still need the human touch, and what AI means for the future of cancer treatment.

Dr. Matthew Kallstrom, thank you so much for joining us today.

And to help us navigate the chronic coronary artery disease landscape, we are truly honored to welcome our expert guest, Dr. Binita Charuntathaway.

Dr. Charuntathaway is a professor of medicine at the Mayo Clinic College of Medicine.

She received her medical degree from Northwestern University and then moved to Rochester, Minnesota, where she completed her internal medicine residency and cardiovascular medicine and nuclear cardiology fellowships.

Additionally, she was an advanced fellow in cardiac PET imaging at the Imperial College School of Medicine in London.